Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Foci Pharma to IPO in Shenzhen

publication date: Dec 5, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Lanzhou Foci Pharma will issue 20.2 million shares in its IPO on the Shenzhen Small and Medium Enterprise Exchange. The expected date is December 13th. The new shares will comprise 25% of the company’s post-IPO capitalization of 80.8 million shares. Founded in Shanghai in 1929, Foci Pharma mainly sells and distributes patented TCMs, although it also deals in western drugs and raw herbs. More details....

Stock Symbol: (SHE: 002644)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...